Cargando…

Cardioprotective effects of short-term empagliflozin treatment in db/db mice

Sodium glucose transporter (SGLT)-2 inhibitors have consistently shown cardioprotective effects independent of the glycemic status of treated patients. In this study we aimed to investigate underlying mechanisms of short-term empagliflozin treatment in a mouse model of type II diabetes. Male db/db m...

Descripción completa

Detalles Bibliográficos
Autores principales:	Radlinger, Bernhard, Hornsteiner, Florian, Folie, Sabrina, Salvenmoser, Willi, Haubner, Bernhard J., Schuetz, Thomas, Haas, Simone, Ress, Claudia, Adolph, Timon E., Salzmann, Karin, Weiss, Bernhard, Tilg, Herbert, Kaser, Susanne
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7665199/ https://www.ncbi.nlm.nih.gov/pubmed/33184414 http://dx.doi.org/10.1038/s41598-020-76698-8

Ejemplares similares

Empagliflozin protects mice against diet-induced obesity, insulin resistance and hepatic steatosis
por: Radlinger, Bernhard, et al.
Publicado: (2022)

Metabolic effects of reduced growth hormone action in fatty liver disease
por: Rufinatscha, Kerstin, et al.
Publicado: (2018)

Empagliflozin alleviates podocytopathy and enhances glomerular nephrin expression in db/db diabetic mice
por: Klimontov, Vadim V, et al.
Publicado: (2020)

Antidiabetic and Cardioprotective Effects of Pharmacological Inhibition of GRK2 in db/db Mice
por: Cipolletta, Ersilia, et al.
Publicado: (2019)

Empagliflozin inhibits coronary microvascular dysfunction and reduces cardiac pericyte loss in db/db mice
por: Tu, Yimin, et al.
Publicado: (2022)

ProteomicsDB
por: Schmidt, Tobias, et al.
Publicado: (2018)

Empagliflozin Ameliorates Type 2 Diabetes-Induced Ultrastructural Remodeling of the Neurovascular Unit and Neuroglia in the Female db/db Mouse
por: Hayden, Melvin R., et al.
Publicado: (2019)

Early combination therapy of empagliflozin and linagliptin exerts beneficial effects on pancreatic β cells in diabetic db/db mice
por: Fushimi, Yoshiro, et al.
Publicado: (2021)

Exocrine Pancreatic Insufficiency in Type 1 and Type 2 Diabetes
por: Radlinger, Bernhard, et al.
Publicado: (2020)

Once daily administration of the SGLT2 inhibitor, empagliflozin, attenuates markers of renal fibrosis without improving albuminuria in diabetic db/db mice
por: Gallo, Linda A., et al.
Publicado: (2016)

Cosmos DB for MongoDB developers: migrating to Azure Cosmos DB and using the MongoDB API
por: Sharma, Manish
Publicado: (2018)

Erratum: Once daily administration of the SGLT2 inhibitor, empagliflozin, attenuates markers of renal fibrosis without improving albuminuria in diabetic db/db mice
por: Gallo, Linda A., et al.
Publicado: (2016)

SGLT2 Inhibitor Empagliflozin and DPP4 Inhibitor Linagliptin Reactivate Glomerular Autophagy in db/db Mice, a Model of Type 2 Diabetes
por: Korbut, Anton I., et al.
Publicado: (2020)

GOLD.db: genomics of lipid-associated disorders database
por: Hackl, Hubert, et al.
Publicado: (2004)

Debuncher DB1 (DB2 and DB3): 1 A06 - 000 - 1
por: Boltezar, E
Publicado: (1970)

Debuncher DB1 (DB2 and DB3): I A06-000-1
por: Boltezar, E
Publicado: (1970)

Anti-diabetic activities of catalpol in db/db mice
por: Bao, Qinwen, et al.
Publicado: (2016)

Antidiabetic and Antiobesity Effects of Artemether in db/db Mice
por: Guo, Yu, et al.
Publicado: (2018)

Resistin Production from Adipose Tissue Is Decreased in db/db Obese Mice, and Is Reversed by Rosiglitazone
por: Ye, Hongying, et al.
Publicado: (2013)

Berkeley DB
por: New Riders
Publicado: (2001)

MongoDB basics : a quick introduction to MongoDB
por: Hows, David, et al.
Publicado: (2014)

Practical MongoDB: architecting, developing, and administering MongoDB
por: Edward, Shakuntala Gupta, et al.
Publicado: (2015)

Segmentation of the Pathophysiological Stages of Diabetic Changes in the db/db Mouse
por: Yamazaki, Masaki, et al.
Publicado: (2009)

Betaine Alleviates Hypertriglycemia and Tau Hyperphosphorylation in db/db Mice
por: Jung, Ga-young, et al.
Publicado: (2013)

Mibefradil reduces blood glucose concentration in db/db mice
por: Lu, Yujie, et al.
Publicado: (2014)

Effect of Ezetimibe on Insulin Secretion in db/db Diabetic Mice
por: Zhong, Yong, et al.
Publicado: (2012)

Mycophenolate Mofetil Ameliorates Diabetic Nephropathy in db/db Mice
por: Seo, Jung-Woo, et al.
Publicado: (2015)

Neuregulin 1 Improves Glucose Tolerance in db/db Mice
por: Ennequin, Gaël, et al.
Publicado: (2015)

Antihyperglycemic and Antiobesity Effects of JAL2 on db/db Mice
por: Lee, In-Seung, et al.
Publicado: (2016)

Retinal Neurodegeneration in db/db Mice at the Early Period of Diabetes
por: Yang, Qin, et al.
Publicado: (2015)

Astragaloside IV ameliorates renal injury in db/db mice
por: Sun, Huili, et al.
Publicado: (2016)

Impaired Muscle Regeneration in Ob/ob and Db/db Mice
por: Nguyen, Mai-Huong, et al.
Publicado: (2011)

Diabetes Alters Diurnal Rhythm of Electroretinogram in db/db Mice
por: Di, Rong, et al.
Publicado: (2019)

Zinc Prevents the Development of Diabetic Cardiomyopathy in db/db Mice
por: Wang, Shudong, et al.
Publicado: (2017)

Dapagliflozin protects against nonalcoholic steatohepatitis in db/db mice
por: Qiao, Panshuang, et al.
Publicado: (2022)

Reversal of murine alcoholic steatohepatitis by pepducin-based functional blockade of interleukin-8 receptors
por: Wieser, Verena, et al.
Publicado: (2017)

MongoDB in action: covers MongoDB version 3.0
por: Banker, Kyle
Publicado: (2016)

Protective Effects of Astragaloside IV on db/db Mice with Diabetic Retinopathy
por: Ding, Yuzhi, et al.
Publicado: (2014)

An age-dependent alteration of the respiratory exchange ratio in the db/db mouse
por: Choi, Hye-Min, et al.
Publicado: (2015)

Linagliptin alleviates fatty liver disease in diabetic db/db mice
por: Michurina, Svetlana V, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_5l905jaf1gsempffh1vsoddl7c